Observation on the Therapeutic Effect of Huaier Granules in the Adjuvant Treatment of Non-small Cell Lung Cancer After Radical Surgery

This study observes whether Huaier Granules — a traditional Chinese herbal medicine — help improve outcomes in patients with non-small cell lung cancer (NSCLC) who have recently had curative surgery. Participants are followed to track survival, recurrence, and quality of life. **You may be eligible if...** - You are between 18 and 75 years old with confirmed non-small cell lung cancer (stage II–IIIA) - You had curative (R0) surgery within the last 2 months and have not yet started any other treatment - Your general health status is good (ECOG 0–2) **You may NOT be eligible if...** - You are allergic to Huaier Granule ingredients - You have difficulty swallowing or gastrointestinal issues that prevent taking oral medication - You plan to receive chemotherapy, immunotherapy, radiation, or other targeted cancer drugs during the study - You have had another cancer in the last 5 years - You have taken other herbal anti-tumor medicines in the past month - You are pregnant or breastfeeding Talk to your doctor to see if this trial is right for you.